Summary Psychosocial factors are thought to influence risk and survival from cancer. We have previously studied specific behaviours in transgenic male CD-1 MT42 mice, which overexpress the gene encoding human transforming growth factor a (TGFa) in multiple tissues, and which Transforming growth factor a (TGFa) is a polypeptide which exhibits approximately 35% sequence homology to epidermal growth factor (EGF), and interacts with cells through the EGF receptor. Both TGFx and EGF can act as potent mitogens in a number of epithelial cell systems (Carpenter & Cohen, 1979). It has been postulated that TGFa plays an important role in neoplastic transformation, since it is highly expressed along with its receptor in many TGFa growth responsive tumour cells (Bates et al., 1988; Derynck et al., 1987; Rosenthal et al., 1986; Watanabe et al., 1987) . The results of studies with transgenic CD-1 mice, in which chronic overexpression of TGFa is directed by the metallothionein (MT) promotor to multiple tissues throughout their life (Jhappan et al., 1990; Sandgren et al., 1990) , have shown that male mice bearing a TGFa transgene develop a high incidence of spontaneous hepatocarcinomas at the age of 10-15 months (Jhappan et al., 1990) . Other abnormalities in these animals (stomach, pancreas, etc.) have emerged as studies have proceeded.
Transforming growth factor a (TGFa) is a polypeptide which exhibits approximately 35% sequence homology to epidermal growth factor (EGF), and interacts with cells through the EGF receptor. Both TGFx and EGF can act as potent mitogens in a number of epithelial cell systems (Carpenter & Cohen, 1979) . It has been postulated that TGFa plays an important role in neoplastic transformation, since it is highly expressed along with its receptor in many TGFa growth responsive tumour cells (Bates et al., 1988; Derynck et al., 1987; Rosenthal et al., 1986; Watanabe et al., 1987) . The results of studies with transgenic CD-1 mice, in which chronic overexpression of TGFa is directed by the metallothionein (MT) promotor to multiple tissues throughout their life (Jhappan et al., 1990; Sandgren et al., 1990) , have shown that male mice bearing a TGFa transgene develop a high incidence of spontaneous hepatocarcinomas at the age of 10-15 months (Jhappan et al., 1990) . Other abnormalities in these animals (stomach, pancreas, etc.) have emerged as studies have proceeded.
Human and animal data suggest that an ability to cope with stress influences vulnerability to develop cancer (Hilakivi-Clarke et al., 1993b; Holland, 1989; Sklar & Anisman, 1981) . Perturbations in natural killer (NK) cell activity (Chuang et al., 1990; Saibara et al., 1989; Shirai et al., 1990) and steroid hormone levels (d'Arville & Johnson, 1990; Yager & Shi, 1991) may mediate the effects of psychosocial factors in cancer. We have utilised transgenic male MT42 TGFax mice in studies assessing those behaviours associated with tumourigenesis (Hilakivi-Clarke et al., 1992a) . When compared with age matched non-tran sgenic control CD-1 mice, 2-3-month-old male transgenic TGFa mice spent significantly longer times immobile in Porsolt's swim test, and in aggressive behaviour (Hilakivi-Clarke et al., 1992a) . The male TGFa mice also exhibited a 25% lower NK cell activity, and a 4-fold increase in the plasma levels of 17p-estradiol (E2) than the controls (Hilakivi-Clarke et al., 1992) . The results suggest that the effects of TGFx on hepatocel-lular carcinoma may be influenced by behaviour, and the immune and hormonal systems.
The present study investigated behavioural and biological parameters in the female transgenic MT42 TGFx mice. These female transgenic TGFa mice show an abnormal development of the mammary gland, but do not develop spontaneous tumours at an increased rate at any site (Jhappan et al., 1990) . This is surprising, since TGFa appears to play a significant role in mammary tumourigenesis (Bates et al., 1988; Liu et al., 1987; Sandgren et al., 1990) , and female mice in other transgenic TGFa models exhibit an increased incidence of mammary tumours (Matsui et al., 1990; Sandgren et al., 1990; Stuart, 1984) . The expression of TGFoa mRNA appears equally elevated in both sexes of MT42 mice (Hilakivi-Clarke et al., 1993a; Jhappan et al., 1990) . To investigate behavioural changes associated with the overexpression of TGFa in the female mice, we utilised (i) Porsolt's swim test, which is thought to measure both depressive behaviour and an animal's ability to cope with stress (Garcia-Marquez & Armario, 1987; Hilakivi et al., 1989; Porsolt et al., 1977) , (ii) the plusmaze test of anxiety (Lister, 1987) , and (iii) the resident-intruder paradigm of aggression (Miczek, 1987) . The NK cell activity, and plasma E2 and testosterone levels were also measured.
The results indicate that female transgenic TGFa mice show significantly shorter immobility in the swim test, and appear less aggressive than their non-transgenic CD-I female controls. In marked contrast, the male TGFa mice develop hepatocellular tumours, exhibit a lengthened immobility in the swim test and are highly aggressive (Hilakivi-Clarke et al., 1992a) . Thus, in addition to the differences in the tumourigenesis, overexpression of TGFa induces genderspecific behavioural alterations.
Methods

Animals
Mice of the CD-I background were made transgenic for the growth factor TGFa (Jhappan et al., 1990) (Jhappan et al., 1990) .
Non-transgenic female CD-1 mice (Charles Rivers, NC) were used as controls. Upon arrival, these 4-5 week old mice were housed in groups of 5-10. The animals were maintained on a 12 h light-12 h dark cycle, and allowed ad libitum access to food and water. When the animals were 123 days old, three female control and three female TGFa mice were killed by cervical dislocation for a pathological examination of their liver and pancreas. These organs were placed in 10% (v/v) formalin, and submitted to Maryland Medical Laboratory (Baltimore, MD) for histological analyses.
Apparatus and behavioural testing procedures Swim test The mice were 73 days old when tested in the swim test. Ten female TGFa and ten controls were used. Each mouse was placed individually in a plastic cylinder (height 17 cm, diameter 21 cm) containing 8 cm of water maintained at about 25°C for 10 min. This 10 min period included a 2 min acclimatisation period at the beginning of the test, immediately followed by an 8 min test. The time spent immobile in the water was scored using a stop-watch (Hilakivi et al., 1989; Porsolt et al., 1977) . A mouse was judged to be immobile when it was floating almost motionless.
Porsolt's swim test has been developed to predict the antidepressant efficacy of different compounds (Porsolt et al., 1977) , but it is also sensitive to the effects of a variety of stressors (Garcia-Marquez & Armario, 1987; Hilakivi et al., 1989) . Antidepressants shorten, and stressors lengthen the time spent immobile in the water.
Resident-intruder test Seven 82-day-old female TGFa and 7 control mice, which were previously used in the swim test, were housed individually for 7 days. Thereafter, these mice were confronted in their home cage with a group-housed non-transgenic female intruder which had no previous contact with the resident. Each intruder was used only once. The body weights of the intruders were matched with those of the residents. During the 8 min test period, an observer monitored the behaviour of the resident using two stop watches. The behaviours recorded were the number and duration of social investigation (sniffing, following, grooming) and aggression (lateral threat, tail rattle, biting, fighting) (Hilakivi-Clarke et al., 1990; Miczek, 1987) .
Plusmaze Behaviour in the plusmaze was measured from nine female TGFx and nine control mice. These mice were 74 days old, and they were put into an open arena for 3 min immediately prior to the plusmaze test (Lister, 1987) . The plusmaze was made of transparent Plexiglas and consisted of two open arms (30 x 5 cm) and two enclosed arms (30 x 5 cm) with 14.5 cm high side walls. The arms extended from a central platform, and the floor of the closed arms was painted black. The apparatus was mounted on a Plexiglas base, raising it 38.5 cm above the floor (Lister, 1987 
Swim test
The time spent immobile in the water was significantly shorter in the female TGFa mice than in their CD-1 controls (t(29) = 2.9, P<.008) (Figure 1 ).
Resident-intruder test
The female TGFoa mice spent a significantly shorter time showing aggressive behaviours than the control mice (t(12) = 2.8, P<.02) (Figure 2 ). When fighting occurred, it was always the resident who initiated the attack. The time spent in active social interactions was also shorter in the female TGFa mice, when compared with the controls (t(12) = 3.9, P <.002).
Plusmaze
The behaviour in the plusmaze did not significantly differ between the female transgenic (mean ± s.e.m. proportion of time spent on open arms: 28.6 ± 3.6%) and non-transgenic mice 22.8 ± 4.9%).
Plasma steroid hormone levels The control mice had a regular 4-5 day estrous cycle. However, only 20% of the TGFx mice cycled regularly; 40% appeared to remain in estrous and 40% in anestrus. Plasma E2 levels were determined from one regularly cycling TGFa E * mice in proestrus, one irregularly cycling TGFa mouse in proestrus, two irregularly cycling TGFx mice in estrus, and one irregularly cycling TGFa mouse in metestrus. The stage of estrous cycle in the control female mice was matched with that of the TGFa mice. The results showed that the plasma levels of E2 were significantly elevated by 3-fold in the female transgenic mice (mean ± s.e.m.; 15.8 ± 1.3 pg ml-' vs controls: 5.0 ± 2.2 pg ml-') (t(1,8) = 4.2 P<.003). In the TGFa mice, the levels did not appear to be dependent on the stage of the estrus cycle, whereas in the non-transgenic mice the levels of E2 were 13-times higher in proestrus than in diestrus. The amount of testosterone in the blood was not significantly different between the female TGFa mice (4.2 ± 0.8 ng ml-') and their controls (2.7 ± 1.1 ng ml'). Natural killer cell activity As shown in Figure 3 , NK cell activity was significantly lower by approximately 75% in the female TGFa mice, when compared with the non-transgenic female control mice (F(2,24) = 13.8, P <.001).
Discussion
The results of our previous study 1 992a) suggested that the effect of an overexpression of TGFx on neoplastic transformation in male transgenic mice may be mediated through a number of factors, including behaviour, and hormonal and immune systems. The present study investigated these same parameters in the female TGFa mice, which do not develop an increased incidence of tumours at any site (Jhappan et al., 1990) . Both the male (Hilakivi-Clarke et al., 1992a) and female TGFa mice express a 3-fold elevation in plasma E2 levels and a 3-fold decrease in NK cell activity. Furthermore, both sexes do not exhibit alterations in the behaviour in the plusmaze test of anxiety.
The effect of an elevated expression of TGFx on behaviour in the swim test and resident-intruder paradigm is different in the male and female transgenic mice. Male transgenic TGFx mice exhibit an elevated level of aggression and an impaired ability to cope with stress in the swim test, when compared with their non-transgenic male CD-1 controls. The data obtained in the present study indicate that in the swim test the female TGFx spend less time immobile than the nontransgenic female control mice, suggesting an improved ability to cope with stress. Furthermore, aggressive behaviour is reduced in the female TGFa mouse. The present results suggest that the overexpression of TGFa induces hepatocellular carcinoma in male transgenic mice, and gender-specific behavioural alterations. Thus, certain behavioural patterns may be associated with tumourigenesis, whereas others may indicate a reduced risk for developing cancer. However, definitive evidence supporting a cause and effect relationship between behaviour and tumourigenesis remains to be determined. The data obtained in both human and animal studies suggest that psychosocial factors may play a role in the development of cancer and influence survival (Hilakivi-Clarke et al., 1993b) . Specifically, these studies implicate that an impaired ability to cope with stress increases the-risk to develop cancer and shortens survival (Hilakivi-Clarke et al., 1993b; Ramirez et al., 1989; Sklar & Anisman, 1981) . In contrast, an improved ability to cope with stress and improved well-being may reduce cancer risk (Geyer, 1991) and lengthen survival (Spiegel et al., 1989) .
Besides its association with neoplastic transformation, the physiological roles of TGFax are largely unknown. TGFa can induce release of luteinising hormone-releasing hormone (LHRH) in the hypothalamus of female rats (Ojeda et al., 1990) . LHRH stimulates the release of luteinising hormone in the pituitary, which in turn stimulates estrogen release from the uterus in females and from the testes in males (Griffin & Ojeda, 1988) . Thus, in the transgenic mice, constitutive TGFa expression may have increased plasma estrogen levels via stimulation of the hypothalamus. Alternatively, TGFa may modulate peripheral conversion of androgens to estrogen via increased activity of the aromatase enzyme .
The estrous cycle of the female TGFa animals was abnormal: the females were either almost constantly in estrus or in anestrus. This may contribute to our difficulties in breeding the TGFa mice. It is possible that the increased plasma E2 levels resulted from the altered estrus cycle. However, female rats exposed to clomipramine during the early postnatal period and subsequently to 7,12-dimethylbenz(a)anthracene, remain in estrus but their plasma E2 levels are not elevated (Hilakivi-Clarke et al., 1993c) . Thus, alterations in estrus cycle do not necessarily lead to a change in plasma E2 levels.
The less depressive-like tendencies apparent in the female TGFa mice suggest that high levels of estrogen may protect from depression, and low levels may induce this behaviour. Ovariectomy increases depressive-like behaviour in female mice (Bernardi et al., 1989) . Estradiol does not affect behaviour in the swim test in intact females, but it reverses the effects of ovariectomy (Bernardi et al., 1989) . Estrogen also influences aggressive behaviour. Experiments conducted by van de Poll et al. (1985) have shown that chronic treatment with estrogen induced high levels of aggression in male but not female rats. These findings are in accordance with the present and earlier data (Hilakivi-Clarke et al., 1992) , indicating that female TGFz mice exhibit less and male TGFa more aggressive behaviour than their non-transgenic CD-I controls.
There are at least three explanations for the present findings. (i) There may be a factor protecting of the females from developing tumours. For example, the female TGFax mice may be 'resistant' to the effects of elevated E2 levels because of their sex, the male TGFa mice being less able to cope with alternating E2 levels. (ii) The interaction between TGFa and estrogen may be critical for liver tumours in male mice, but not in female mice. (iii) It is possible that reduced NK cell activity or increased plasma levels of E2 do not directly participate in neoplastic processes. However, a number of studies strongly support the connection between these biological variables and cancer (d'Arville & Johnson, 1990; Chuang et al., 1990; Yager & Shi, 1991) . Our previous and present results suggest that the elevation in the plasma levels of E2 and reduction in NK cell activity occur independently of the tumourigenic effects of TGFa.
In conclusion, our findings indicate that the female transgenic TGFax mice which do not develop an increased incidence of tumours at any site, are well able to cope with stressful situations and are not aggressive. In contrast, the male TGFa mice which develop hepatocellular carcinoma, exhibit behaviours characteristic of both an impaired ability to cope with stress and increased aggressivity several months prior to the appearance of these tumours (Hilakivi-Clarke et al., 1992) . Thus, the data suggest that TGFa promotes tumour growth only in male transgenic mice, and causes gender-specific behavioural alterations. The mechanisms through which these sex-related differences in behaviour and tumourigenesis are mediated, remain unclear. Our future experiments will determine whether the development of hepatocarcinoma in male TGFa animals is associated with an impaired ability to cope with stress and elevated aggressive tendencies, and/or whether manipulations leading to impaired ability to cope with stress promote tumourigenesis in female TGFa mice. 
